List of Contents

Anti-aging Market Size, Share, and Trends 2024 to 2034

The global anti-aging market size was USD 73 billion in 2024, calculated at USD 77.96 billion in 2025 and is expected to reach around USD 140.94 billion by 2034, expanding at a CAGR of 6.8% from 2025 to 2034.

  • Last Updated : December 2024
  • Report Code : 1597
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anti-aging Market 

5.1. COVID-19 Landscape: Anti-aging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anti-aging Market, By Products Type

8.1. Anti-aging Market, by Products Type, 2025-2034

8.1.1. Anti-wrinkle

8.1.1.1. Market Revenue and Forecast (2022-2034)

8.1.2. Hair color

8.1.2.1. Market Revenue and Forecast (2022-2034)

8.1.3. Ultraviolet absorption

8.1.3.1. Market Revenue and Forecast (2022-2034)

8.1.4. Anti-stretch mark

8.1.4.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Anti-aging Market, By Treatment Type

9.1. Anti-aging Market, by Treatment Type, 2025-2034

9.1.1. Hair restoration

9.1.1.1. Market Revenue and Forecast (2022-2034)

9.1.2. Anti-pigmentation

9.1.2.1. Market Revenue and Forecast (2022-2034)

9.1.3. Adult acne therapy

9.1.3.1. Market Revenue and Forecast (2022-2034)

9.1.4. Breast augmentation

9.1.4.1. Market Revenue and Forecast (2022-2034)

9.1.5. Liposuction

9.1.5.1. Market Revenue and Forecast (2022-2034)

9.1.6. Chemical Peel

9.1.6.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Anti-aging Market, By Demography Type 

10.1. Anti-aging Market, by Demography Type, 2025-2034

10.1.1. Generation X

10.1.1.1. Market Revenue and Forecast (2022-2034)

10.1.2. Baby Boomers

10.1.2.1. Market Revenue and Forecast (2022-2034)

10.1.3. Generation Y

10.1.3.1. Market Revenue and Forecast (2022-2034)

10.1.4. Generation Z

10.1.4.1. Market Revenue and Forecast (2022-2034)

Chapter 11. Global Anti-aging Market, By Devices Type

11.1. Anti-aging Market, by Devices Type, 2025-2034

11.1.1. Anti-cellulite treatment

11.1.1.1. Market Revenue and Forecast (2022-2034)

11.1.2. Laser aesthetic devices

11.1.2.1. Market Revenue and Forecast (2022-2034)

11.1.3. Microdermabrasion devices

11.1.3.1. Market Revenue and Forecast (2022-2034)

11.1.4. Radio frequency devices

11.1.4.1. Market Revenue and Forecast (2022-2034)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2022-2034)

Chapter 12. Global Anti-aging Market, By End User Type

12.1. Anti-aging Market, by End User, 2025-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2022-2034)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2022-2034)

12.1.3. Home healthcare

12.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 13. Global Anti-aging  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Products (2022-2034)

13.1.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.1.3. Market Revenue and Forecast, by Demography (2022-2034)

13.1.4. Market Revenue and Forecast, by Devices (2022-2034)

13.1.5. Market Revenue and Forecast, by End User (2022-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Products (2022-2034)

13.1.6.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.1.6.3. Market Revenue and Forecast, by Demography (2022-2034)

13.1.6.4. Market Revenue and Forecast, by Devices (2022-2034)

13.1.7. Market Revenue and Forecast, by End User (2022-2034) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Products (2022-2034)

13.1.8.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.1.8.3. Market Revenue and Forecast, by Demography (2022-2034)

13.1.8.4. Market Revenue and Forecast, by Devices (2022-2034)

13.1.8.5. Market Revenue and Forecast, by End User (2022-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Products (2022-2034)

13.2.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.2.3. Market Revenue and Forecast, by Demography (2022-2034)

13.2.4. Market Revenue and Forecast, by Devices (2022-2034) 

13.2.5. Market Revenue and Forecast, by End User (2022-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Products (2022-2034)

13.2.6.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.2.6.3. Market Revenue and Forecast, by Demography (2022-2034)

13.2.7. Market Revenue and Forecast, by Devices (2022-2034) 

13.2.8. Market Revenue and Forecast, by End User (2022-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Products (2022-2034)

13.2.9.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.2.9.3. Market Revenue and Forecast, by Demography (2022-2034)

13.2.10. Market Revenue and Forecast, by Devices (2022-2034)

13.2.11. Market Revenue and Forecast, by End User (2022-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Products (2022-2034)

13.2.12.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.2.12.3. Market Revenue and Forecast, by Demography (2022-2034)

13.2.12.4. Market Revenue and Forecast, by Devices (2022-2034)

13.2.13. Market Revenue and Forecast, by End User (2022-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Products (2022-2034)

13.2.14.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.2.14.3. Market Revenue and Forecast, by Demography (2022-2034)

13.2.14.4. Market Revenue and Forecast, by Devices (2022-2034)

13.2.15. Market Revenue and Forecast, by End User (2022-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Products (2022-2034)

13.3.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.3.3. Market Revenue and Forecast, by Demography (2022-2034)

13.3.4. Market Revenue and Forecast, by Devices (2022-2034)

13.3.5. Market Revenue and Forecast, by End User (2022-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Products (2022-2034)

13.3.6.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.3.6.3. Market Revenue and Forecast, by Demography (2022-2034)

13.3.6.4. Market Revenue and Forecast, by Devices (2022-2034)

13.3.7. Market Revenue and Forecast, by End User (2022-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Products (2022-2034)

13.3.8.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.3.8.3. Market Revenue and Forecast, by Demography (2022-2034)

13.3.8.4. Market Revenue and Forecast, by Devices (2022-2034)

13.3.9. Market Revenue and Forecast, by End User (2022-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Products (2022-2034)

13.3.10.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.3.10.3. Market Revenue and Forecast, by Demography (2022-2034)

13.3.10.4. Market Revenue and Forecast, by Devices (2022-2034)

13.3.10.5. Market Revenue and Forecast, by End User (2022-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Products (2022-2034)

13.3.11.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.3.11.3. Market Revenue and Forecast, by Demography (2022-2034)

13.3.11.4. Market Revenue and Forecast, by Devices (2022-2034)

13.3.11.5. Market Revenue and Forecast, by End User (2022-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Products (2022-2034)

13.4.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.4.3. Market Revenue and Forecast, by Demography (2022-2034)

13.4.4. Market Revenue and Forecast, by Devices (2022-2034)

13.4.5. Market Revenue and Forecast, by End User (2022-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Products (2022-2034)

13.4.6.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.4.6.3. Market Revenue and Forecast, by Demography (2022-2034)

13.4.6.4. Market Revenue and Forecast, by Devices (2022-2034)

13.4.7. Market Revenue and Forecast, by End User (2022-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Products (2022-2034)

13.4.8.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.4.8.3. Market Revenue and Forecast, by Demography (2022-2034)

13.4.8.4. Market Revenue and Forecast, by Devices (2022-2034)

13.4.9. Market Revenue and Forecast, by End User (2022-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Products (2022-2034)

13.4.10.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.4.10.3. Market Revenue and Forecast, by Demography (2022-2034)

13.4.10.4. Market Revenue and Forecast, by Devices (2022-2034)

13.4.10.5. Market Revenue and Forecast, by End User (2022-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Products (2022-2034)

13.4.11.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.4.11.3. Market Revenue and Forecast, by Demography (2022-2034)

13.4.11.4. Market Revenue and Forecast, by Devices (2022-2034)

13.4.11.5. Market Revenue and Forecast, by End User (2022-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Products (2022-2034)

13.5.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.5.3. Market Revenue and Forecast, by Demography (2022-2034)

13.5.4. Market Revenue and Forecast, by Devices (2022-2034)

13.5.5. Market Revenue and Forecast, by End User (2022-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Products (2022-2034)

13.5.6.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.5.6.3. Market Revenue and Forecast, by Demography (2022-2034)

13.5.6.4. Market Revenue and Forecast, by Devices (2022-2034)

13.5.7. Market Revenue and Forecast, by End User (2022-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Products (2022-2034)

13.5.8.2. Market Revenue and Forecast, by Treatment (2022-2034)

13.5.8.3. Market Revenue and Forecast, by Demography (2022-2034)

13.5.8.4. Market Revenue and Forecast, by Devices (2022-2034)

13.5.8.5. Market Revenue and Forecast, by End User (2022-2034)

Chapter 14. Company Profiles

14.1. Unilever Group

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GALDERMA LABORATORIES L.P.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Procter & Gamble (P&G) Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Nu Skin Enterprises Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Hologic Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Pierre Fabre S.A.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Shiseido Company Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Candela Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Home Skinovations Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Estee Lauder

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global anti-aging market was reached at USD 73 billion in 2024 and is anticipated to rake USD 140.94 billion by 2034.

The global anti-aging market is growing at a CAGR of 6.8% over the forecast period 2025 to 2034.

The major players operating in the anti-aging market are Unilever Group, GALDERMA LABORATORIES L.P., Procter & Gamble (P&G) Company, Nu Skin Enterprises Inc., Hologic Inc., Pierre Fabre S.A., Shiseido Company Limited, Candela Corporation, Home Skinovations Ltd., and Estee Lauder.

The anti-aging market is propelled by not only by the aging population, but also by the young population who are starting in their mid-age, care about their skin, body, and hair in order to delay the aging process particularly with their appearance.

North America region will lead the global anti-aging market over the forecast period.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us